Ironwood Pharmaceuticals, Inc.
IRWD
$1.27
$0.000.00%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 308.52M | 317.68M | 351.41M | 378.42M | 400.57M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 308.52M | 317.68M | 351.41M | 378.42M | 400.57M |
| Cost of Revenue | 2.15M | 9.17M | 7.55M | 26.77M | 29.73M |
| Gross Profit | 306.37M | 308.51M | 343.86M | 351.65M | 370.84M |
| SG&A Expenses | 110.76M | 130.93M | 144.27M | 157.65M | 153.88M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 216.78M | 243.97M | 255.69M | 283.06M | 282.25M |
| Operating Income | 91.74M | 73.71M | 95.72M | 95.36M | 118.32M |
| Income Before Tax | 42.91M | 23.97M | 65.20M | 71.56M | 86.13M |
| Income Tax Expenses | 50.80M | 56.31M | 64.32M | 74.68M | 78.94M |
| Earnings from Continuing Operations | -7.89 | -32.34 | 0.88 | -3.12 | 7.18 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | 658.00K | 2.03M |
| Net Income | -7.89M | -32.34M | 880.00K | -2.46M | 9.21M |
| EBIT | 91.74M | 73.71M | 95.72M | 95.36M | 118.32M |
| EBITDA | 94.08M | 76.09M | 98.13M | 97.80M | 120.36M |
| EPS Basic | -0.05 | -0.20 | 0.01 | -0.02 | 0.06 |
| Normalized Basic EPS | 0.24 | 0.18 | 0.27 | 0.27 | 0.38 |
| EPS Diluted | -0.06 | -0.21 | -0.01 | -0.03 | 0.04 |
| Normalized Diluted EPS | 0.23 | 0.18 | 0.27 | 0.27 | 0.35 |
| Average Basic Shares Outstanding | 641.85M | 639.14M | 635.87M | 632.43M | 628.61M |
| Average Diluted Shares Outstanding | 657.49M | 639.67M | 636.40M | 632.96M | 659.62M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |